Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Paul Atkins, the Trump administration nominee to lead the Securities and Exchange Commission, experienced the most scrutiny of the day.

What we learned from Banking noms, plus a tax letter

The Senate Banking Committee hosted a quartet of Trump administration nominees this morning. The setup led to a flurry of policy talk, with senators bouncing from banking and securities deregulation, debanking, tariffs, supervisory risk management and the banking crises of the last two decades.

The four regulatory nominees all emerged from the hearing relatively unscathed, with Banking Chair Tim Scott (R-S.C.) hailing the group as “an opportunity to take another step toward reigniting President Trump's blue-collar comeback.” We don’t expect any to have a problem getting confirmed. But we learned some stuff in the process.

Subscripion logo

You're seeing a preview of our Premium Policy: The Vault financial services and tax policy coverage. Read the full story by subscribing here.

Presented by Pharmaceutical Reform Alliance

Americans know who to blame for rising drug prices: Big Pharma. Most Republicans, Democrats, & Independents all believe Big Pharma is stealing from Americans, one prescription at a time. Let’s hold them accountable and put Americans first.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.